ReviewAdvances in experimental medicine and biology2025
Signaling Pathways in Retinal Pigment Epithelium (RPE) Cells in Response to Stress Conditions of Age-Related Macular Degeneration (AMD).
Review in Advances in experimental medicine and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Age-related macular degeneration (AMD), affecting circa 200 million people worldwide, is a debilitating disease leading to visual loss in the elderly population. The main risk for AMD is advanced age. Genetic predisposition as well as modern lifestyle habits, such as smoking or unhealthy diets, increase this risk. On the molecular level, these risks convert into complex systemic changes at the interface of the choriocapillaris, Bruch's membrane, RPE, and neuroretina, affecting the functional integrity and survival of RPE and photoreceptors cells. To date, therapeutic options for AMD patients are limited. Pathway identification and a detailed understanding of the molecular mechanisms driving AMD are prerequisites to defining potential novel druggable targets. This review aims to give a short overview of the known cell signaling pathways focusing on RPE cells in response to stress conditions occurring in AMD.
Indexed as
Identifiers
39930220What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.